“…By inhibiting SPT, myriocin disrupts sphingolipid generation leading to varied sphingolipid profiles within cells. Myriocin, thus, has been used to investigate the impact of altered sphingolipid levels on cellular processes, including cellular signaling, immune cell function, apoptosis, autophagy, and membrane dynamics, to name a few ( Scarlatti et al, 2003 ; Johnson et al, 2004 ; Rentz et al, 2005 ; Ordoñez et al, 2015 ; Guo et al, 2020 ; Yu et al, 2022 ). It has also been instrumental in understanding the roles of sphingolipids in various diseases, such as cancer, cardiovascular diseases, and neurodegenerative disorders ( Park et al, 2008 ; Adachi et al, 2018 ; Mingione et al, 2021 ; Weiss et al, 2021 ).…”